The Estee Lauder Companies (EL)
(Delayed Data from NYSE)
$63.28 USD
-2.58 (-3.92%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $63.50 +0.22 (0.35%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth B Momentum F VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$63.28 USD
-2.58 (-3.92%)
Updated Nov 6, 2024 04:00 PM ET
After-Market: $63.50 +0.22 (0.35%) 7:58 PM ET
5-Strong Sell of 5 5
F Value D Growth B Momentum F VGM
Zacks News
Coty (COTY) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Coty (COTY) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Estee Lauder (EL) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Estee Lauder (EL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Nu Skin Enterprises (NUS) Q2 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
Nu Skin (NUS) delivered earnings and revenue surprises of 16.67% and 2.11%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Natura & Co Holding (NTCOY) Moves 5.3% Higher: Will This Strength Last?
by Zacks Equity Research
Natura & Co Holding (NTCOY) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Olaplex Holdings, Inc. (OLPX) Q2 Earnings Meet Estimates
by Zacks Equity Research
Olaplex (OLPX) delivered earnings and revenue surprises of 0% and 0.99%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Implied Volatility Surging for Estee Lauder (EL) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Estee Lauder (EL) stock based on the movements in the options market lately
e.l.f. Beauty (ELF) Down 20% in a Month: Should You Buy the Dip?
by Vrishali Bagree
e.l.f. Beauty's (ELF) approach to adapting to consumer trends and enhancing operational effectiveness underscores its potential for recovery amid stiff competition and changing consumer preferences.
Estee Lauder (EL) on Track With Profit Recovery Amid Hurdles
by Zacks Equity Research
Estee Lauder (EL) is on track to operationalize the Profit Recovery Plan to focus on rebuilding stronger and more sustainable profitability alongside supporting sales growth.
These 2 Consumer Staples Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
Profit Recovery Aids Estee Lauder (EL), Soft Asia Region Ails
by Zacks Equity Research
Estee Lauder's (EL) Profit Recovery Plan is aimed at fortifying profitability, fostering accelerated sales growth and enhancing agility. However, softness in the mainland China region is a concern.
Estee Lauder (EL) Concludes Buyout of DECIEM, Boosts Portfolio
by Zacks Equity Research
Estee Lauder's (EL) acquisition of DECIEM, the innovative "Abnormal Beauty Company," enhances its skincare lineup, fostering global expansion.
Estee Lauder (EL) Down 10% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Estee Lauder (EL) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Estee Lauder's (EL) Profit Recovery on Track Despite Hurdles
by Zacks Equity Research
Estee Lauder (EL) benefits from the Profit Recovery Plan and robust presence in emerging markets. However, macroeconomic challenges like softness in the mainland China region are a concern.
Is Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for GSEW
Zacks Industry Outlook Highlights Estee Lauder, Coty, Helen of Troy and European Wax Center
by Zacks Equity Research
Estee Lauder, Coty, Helen of Troy and European Wax Center have been highlighted in this Industry Outlook article.
4 Cosmetics Stocks Worth Watching Despite Industry Headwinds
by Ansuiya Mohta
The Zacks Cosmetics industry is grappling with rising costs and supply chain disruptions. Estee Lauder Companies (EL), COTY, Helen of Troy (HELE) and European Wax Center (EWCZ) are capitalizing on digital advancements and innovative strategies.
Estee Lauder (EL) Reliance on International Sales: What Investors Need to Know
by Zacks Equity Research
Review Estee Lauder's (EL) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
Should Goldman Sachs Equal Weight U.S. Large Cap Equity ETF (GSEW) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for GSEW
Estee Lauder (EL) Ups FY24 Profit View on Q3 Earnings Beat
by Zacks Equity Research
Estee Lauder's (EL) third-quarter fiscal 2024 results reflect higher net sales and earnings organic sales on growth across Asia travel retail. Management ups fiscal 2024 earnings view.
Private Payrolls in April Exceed Expectations
by Zacks Equity Research
Private Payrolls in April Exceed Expectations.
ADP Reports Still-Strong Labor Market; MA, EL Beat
by Mark Vickery
Off lows of late '23 and early '24, private-sector jobs growth looks to be warming up again.
Estee Lauder (EL) Reports Q3 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
Although the revenue and EPS for Estee Lauder (EL) give a sense of how its business performed in the quarter ended March 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Estee Lauder (EL) Q3 Earnings and Revenues Top Estimates
by Zacks Equity Research
Estee Lauder (EL) delivered earnings and revenue surprises of 102.08% and 0.39%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?
Should You Buy Estee Lauder Companies (EL) Ahead of Earnings?
by Zacks Equity Research
Estee Lauder Companies (EL) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Here's How Clorox (CLX) is Placed Ahead of Q3 Earnings Release
by Zacks Equity Research
Clorox (CLX) third-quarter results are likely to reflect challenges related to continued impacts of the recent cyberattack incident, inflationary costs and elevated SG&A expense.